Monopar Therapeutics, Inc. (MNPR)
74.60
-2.44
(-3.17%)
USD |
NASDAQ |
Dec 12, 16:00
74.46
-0.14
(-0.19%)
After-Hours: 20:00
Monopar Therapeutics Total Assets (Quarterly): 144.20M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 904.95M |
| Travere Therapeutics, Inc. | 538.58M |
| Xenetic Biosciences, Inc. | 5.068M |
| KalVista Pharmaceuticals, Inc. | 339.93M |
| BeyondSpring, Inc. | 29.48M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.639M |
| Shareholders Equity (Quarterly) | 141.56M |
| Debt to Equity Ratio | 0.0005 |
| Current Ratio | 56.10 |
| Net Debt Paydown Yield | -0.00% |